HRCT-features of Pneumocystis jiroveci pneumonia and their evolution before and after treatment in non-HIV immunocompromised patients
Introduction
Pneumonias are among the most frequent, life threatening infectious complications in immunocompromised patients. The incidence of pneumonia by Pneumocystis jiroveci, the former carinii (PJP) is estimated to be below 2% in patients with solid tumors and collagen vascular diseases undergoing steroid therapy. In transplant recipients, an incidence of 5–10% is reported [1]. The most common symptoms include progressive dyspnoea, non-productive dry cough and a light fever [2]. A thin-section CT is considered the most reliable imaging modality in detecting and differentiating pneumonia in immunocompromised patients [3], [4]. Given the wide availability of CT-scanners, follow up-examinations for therapy monitoring in severely ill patients with infectious pulmonary complications can be easily performed. As a consequence, knowledge about the normal temporal course of PJP is essential, to assure correctness of diagnosis and assess appropriate response to therapy. Furthermore, it seems relevant, whether a chronic lung disease such as fibrosis is likely to be a consequence of a preceding PJP. Pulmonary fibrosis including multiple thin walled cysts, which is variable in occurrence and severity, and is even radiographically observed in 10–34% of PJP-patients [5]. However, there is little data existent about the morphology of late changes in HIV-negative patients, as this feature has mainly been described in patients with AIDS both by radiologists and by pathologist as a late sequelae of PJP and as a common cause of spontaneous pneumothorax [1], [6], [7], [8], [9].
The CT-morphology of acute PJP has been extensively analyzed and described as multifaceted. The most frequent pattern in the early phase of the disease is extensive ground glass opacity (GGO) with predilection for the apical and central lung regions [3], [6], [10], [11], [12], [13]. To our knowledge no data exists about the course, duration and morphology of chronic pulmonary changes as depicted on thin-section-CT in non-HIV immunocompromised patients with PJP.
The aim of this retrospective study was to determine the frequency, morphology and the evolution of pulmonary findings in PJP as depicted by thin-section-CT in non-HIV patients.
Section snippets
Patients
Patients for the study were identified by positive broncho-alveolar lavage (BAL) for P. jiroveci in the database of our institute for microbiology. Database search covered the time period from January 2002 to June 2009. A total of 187 PJP patients were identified, 84 were included in the study. Inclusion criteria were the availability of chest-CT-examinations before (CT0), during and after PJP, the absence of HIV-infection, pulmonary co-infection or co-morbidity during the examined time period,
Results
All of the 187 patients with BAL positive for P. jiroveci had undergone chest-CT within a median time frame of ±1 (range ±6) days. Of these 187 patients, 89 were excluded because of lacking CT0 performed before onset of pulmonary symptoms. Nine of the remaining 98 patients had to be excluded for suspected or proven coinfection or pulmonary comorbidity such as toxic lung damage due to medication (n = 2), transfusion induced lung injury (n = 1), pulmonary aspergillosis (n = 2), CMV-infection (n = 2),
Discussion
Chest CT scans are increasingly performed for diagnosis and therapeutic monitoring of pneumonia in immunocompromised patients. To our knowledge, to date no data about the temporal course of pulmonary CT findings in non-HIV-PJP have been reported. In our retrospective study morphological changes in 84 PJP patients were followed over a period of up to 506 days.
The initial appearance of PJP was similar to previously reported symmetric, apically distributed GGO with perihilar location, a mosaic
Conclusion
Signs of acute PJP often resolve quickly after the application of specific antimicrobial therapy. Architectural distortions do not regularly occur following PJP and are often reversible in HIV-negative patients receiving adjunctive corticosteroids.
References (16)
- et al.
Etiology of spontaneous pneumothorax in 105 HIV-infected patients without highly active antiretroviral therapy
Eur J Radiol
(2009) - et al.
Roentgenographic patterns of Pneumocystis carinii pneumonia in 104 patients with AIDS
CHEST
(1987) - et al.
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia
CHEST
(1998) Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome
Infect Dis
(2002)- et al.
Pneumocystis pneumonia
NEJM
(2004) - et al.
High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal equivocal or nonspecific radiographic findings
AJR
(1997) - et al.
Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients
Eur Radiol
(2002) - et al.
Pulmonary fungal infection: Imaging findings in immunocompetent and immunocompromised patients
Eur J Radiol
(2006)
Cited by (75)
Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation
2023, Infectious Disease Clinics of North AmericaHow to diagnose and treat a patient without human immunodeficiency virus infection having Pneumocystis jirovecii pneumonia?
2023, Clinical Microbiology and InfectionThoracic Infections in Solid Organ Transplants: Radiological Features and Approach to Diagnosis
2022, Radiologic Clinics of North AmericaPneumocystis jirovecii in immunocompromised patients with rheumatic diseases
2021, Reumatologia ClinicaA machine learning diagnostic model for Pneumocystis jirovecii pneumonia in patients with severe pneumonia
2023, Internal and Emergency Medicine
- 1
Tel.: +49 7071 2987210; fax: +49 7071 295845.
- 2
Tel.: +49 7071 2987210.
- 3
Tel.: +49 6221 5637829.
- 4
Tel.: +49 7071 2987299.